Cargando…

Fluorinated Eu(II)-based multimodal contrast agent for temperature- and redox-responsive magnetic resonance imaging

Magnetic resonance imaging (MRI) using redox-active, Eu(II)-containing complexes is one of the most promising techniques for noninvasively imaging hypoxia in vivo. In this technique, positive (T(1)-weighted) contrast enhancement persists in areas of relatively low oxidizing ability, such as hypoxic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Basal, Lina A., Bailey, Matthew D., Romero, Jonathan, Ali, Meser M., Kurenbekova, Lyazat, Yustein, Jason, Pautler, Robia G., Allen, Matthew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Royal Society of Chemistry 2017
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933353/ https://www.ncbi.nlm.nih.gov/pubmed/29780447 http://dx.doi.org/10.1039/c7sc03142d

Ejemplares similares

Toward quantification of hypoxia using fluorinated Eu(II/III)-containing ratiometric probes
por: Subasinghe, S. A. Amali S., et al.
Publicado: (2023)

Oxidation-Responsive, Eu(II/III)-Based, Multimodal Contrast Agent for Magnetic Resonance and Photoacoustic Imaging
por: Basal, Lina A., et al.
Publicado: (2017)

Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential
por: Techavichit, Piti, et al.
Publicado: (2016)

Hydrophilic fluorinated molecules for spectral (19)F MRI
por: Tanifum, Eric A., et al.
Publicado: (2018)

Dual-Mode Tumor Imaging Using Probes That Are Responsive to Hypoxia-Induced Pathological Conditions
por: Subasinghe, S. A. Amali S., et al.
Publicado: (2022)

Synthesis, Characterization, and Handling of Eu(II)-Containing Complexes for Molecular Imaging Applications
por: Basal, Lina A., et al.
Publicado: (2018)

Metabolic modulation of Ewing sarcoma cells inhibits tumor growth and stem cell properties
por: Dasgupta, Atreyi, et al.
Publicado: (2017)

MYC regulates CSF1 expression via microRNA 17/20a to modulate tumor-associated macrophages in osteosarcoma
por: Nirala, Bikesh K., et al.
Publicado: (2023)

Fluorine-19 MRI Contrast Agents for Cell Tracking and Lung Imaging
por: Fox, Matthew S., et al.
Publicado: (2016)

K-Ras and p53 mouse model with molecular characteristics of human rhabdomyosarcoma and translational applications
por: Nakahata, Kengo, et al.
Publicado: (2022)

A liposomal Gd contrast agent does not cross the mouse placental barrier
por: Shetty, Anil N., et al.
Publicado: (2016)

Corrigendum: A liposomal Gd contrast agent does not cross the mouse placental barrier
por: Shetty, Anil N., et al.
Publicado: (2017)

Early detection of myocardial changes with and without dexrazoxane using serial magnetic resonance imaging in a pre-clinical mouse model
por: Noel, Cory V., et al.
Publicado: (2021)

Cross-species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma
por: Allen-Rhoades, Wendy, et al.
Publicado: (2015)

A Hyperfluorinated Hydrophilic Molecule for Aqueous (19)F MRI Contrast Media
por: Tanifum, Eric A., et al.
Publicado: (2018)

Low-molecular-weight paramagnetic (19)F contrast agents for fluorine magnetic resonance imaging
por: Herynek, Vít, et al.
Publicado: (2018)

Fluorinated hydrogel nanoparticles with regulable fluorine contents and T(2) relaxation times as (19)F MRI contrast agents
por: Duan, Ziwei, et al.
Publicado: (2023)

Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastoma
por: Zhuang, Danping, et al.
Publicado: (2022)

Pharmocologic treatment with histone deacetylase 6 inhibitor (ACY-738) recovers Alzheimer's disease phenotype in amyloid precursor protein/presenilin 1 (APP/PS1) mice
por: Majid, Tabassum, et al.
Publicado: (2015)

Suppression of the redox reaction between the IGZO surface and the reducing agent TMA using fluorine oxidizing agent treatment
por: Jang, Yuseong, et al.
Publicado: (2023)

Functionalized Gold Nanoparticles as Contrast Agents for Proton and Dual Proton/Fluorine MRI
por: Şologan, Maria, et al.
Publicado: (2019)

Nitroxyl Radical as a Theranostic Contrast Agent in Magnetic Resonance Redox Imaging
por: Matsumoto, Ken-ichiro, et al.
Publicado: (2022)

A Mouse Holder for Awake Functional Imaging in Unanesthetized Mice: Applications in (31)P Spectroscopy, Manganese-Enhanced Magnetic Resonance Imaging Studies, and Resting-State Functional Magnetic Resonance Imaging
por: Fadel, Lindsay C., et al.
Publicado: (2022)

Development of N-F fluorinating agents and their fluorinations: Historical perspective
por: Umemoto, Teruo, et al.
Publicado: (2021)

Mitochondrial superoxide: a key player in Alzheimer's disease
por: Massaad, Cynthia A., et al.
Publicado: (2009)

Multimodal Contrast Agents for Optoacoustic Brain Imaging in Small Animals
por: Shi, Xue-feng, et al.
Publicado: (2021)

Strategies for Optimizing Water-Exchange Rates of Lanthanide-Based Contrast Agents for Magnetic Resonance Imaging
por: Siriwardena-Mahanama, Buddhima N., et al.
Publicado: (2013)

TRPV1-mediated Pharmacological Hypothermia Promotes Improved Functional Recovery Following Ischemic Stroke
por: Cao, Zhijuan, et al.
Publicado: (2017)

Multimeric Near IR–MR Contrast Agent for Multimodal In Vivo Imaging
por: Harrison, Victoria S. R., et al.
Publicado: (2015)

Bioinspired magnetic nanoparticles as multimodal photoacoustic, photothermal and photomechanical contrast agents
por: Nima, Zeid A., et al.
Publicado: (2019)

Tuning the pH of Activation of Fluorinated Hydrazone-Based Switches—A Pathway to Versatile (19)F Magnetic Resonance Imaging Contrast Agents
por: Janasik, Dawid, et al.
Publicado: (2023)

Reactivity of redox sensitive paramagnetic nitroxyl contrast agents with reactive oxygen species
por: Nyui, Minako, et al.
Publicado: (2019)

Activatable Nanoparticles: Recent Advances in Redox-Sensitive Magnetic Resonance Contrast Agent Candidates Capable of Detecting Inflammation
por: Nwasike, Chukwuazam, et al.
Publicado: (2021)

Incorporation of paramagnetic, fluorescent and PET/SPECT contrast agents into liposomes for multimodal imaging
por: Mitchell, Nick, et al.
Publicado: (2013)

Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy
por: Cai, Xiaoxia, et al.
Publicado: (2019)

Multimodal Imaging of Pancreatic Ductal Adenocarcinoma Using Multifunctional Nanoparticles as Contrast Agents
por: Zhao, Ying, et al.
Publicado: (2020)

Carbon Quantum Dots Conjugated Rhodium Nanoparticles as Hybrid Multimodal Contrast Agents
por: Saladino, Giovanni M., et al.
Publicado: (2021)

Label-Free Iron Oxide Nanoparticles as Multimodal Contrast Agents in Cells Using Multi-Photon and Magnetic Resonance Imaging
por: Reynders, Hendrik, et al.
Publicado: (2021)

Endocardial border delineation capability of a novel multimodal polymer-shelled contrast agent
por: Larsson, Malin K, et al.
Publicado: (2014)

Gd and Eu Co-Doped Nanoscale Metal–Organic Framework as a T(1)–T(2) Dual-Modal Contrast Agent for Magnetic Resonance Imaging
por: Wang, Geoffrey D., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sv6ksbhioptp2n58ptuk00lcr8